The Role of NGS Panels in Rare Disease Diagnosis
Challenges in Rare Disease Diagnosis
Rare diseases are notoriously difficult to diagnose. Patients often experience a long “diagnostic odyssey,” undergoing multiple tests and hospital visits before reaching a conclusion. One of the main challenges is genetic heterogeneity—while many rare diseases have a genetic basis, the number of potential causative genes can be in the hundreds or even thousands. Relying on single-gene testing alone is often insufficient, time-consuming, and resource-intensive. As a result, clinicians and researchers increasingly seek more comprehensive solutions.
The Emergence of Next-Generation Sequencing (NGS)
NGS (Next-Generation Sequencing) has transformed genetic testing by enabling the simultaneous analysis of hundreds to thousands of genes. Its advantages make it particularly well-suited for rare disease diagnostics:
- Multi-Gene Coverage
– Simultaneous testing of multiple candidate genes
– Significantly reduces the time to diagnosis - High Sensitivity and Accuracy
– Detects low-frequency variants, insertions/deletions (Indels), and copy number variations (CNVs)
– Identifies mutations that traditional methods often miss - Cost-Effectiveness
– Reduces the need for multiple sequential single-gene tests
– Lowers both financial burden and time investment for patients and institutions
Rare Disease-Focused NGS Panels
The true value of an NGS panel lies not only in the number of genes it includes but also in how well it is designed and validated for clinical relevance. Different types of panels are currently used in research and clinical practice:
- Focused Panels: Target a specific disease group (e.g., neuromuscular, cardiovascular disorders)
- Comprehensive Panels: Broader coverage to maximize diagnostic yield
- Custom Panels: Tailored to the specific requirements of a hospital, research group, or project
This flexibility makes NGS panels a powerful tool for both clinical diagnostics and translational research in rare disease genomics.
Growing Demand in Hospitals and Medical Foundations
Hospitals and medical research foundations worldwide are increasingly adopting NGS panel-based testing. Several scenarios drive the demand for tailored panel development:
- Specialized panels for patient cohorts (e.g., pediatric rare disease patients)
- Research projects funded by national or international initiatives
- Establishment of in-house diagnostic panels within hospitals
- Regular updates to existing panels as new disease-associated genes are discovered
In this context, having access to a partner that can design and develop high-quality custom NGS panels is becoming essential.
How Celemics Can Contribute
Celemics provides a broad range of NGS-based solutions, including custom panel development that meets the needs of hospitals and research institutions. Key strengths include:
- Panel Design Expertise: Incorporating clinically relevant genes, optimized for uniform coverage and GC-rich or repetitive regions
- High-Quality Sequencing: Ensuring uniform depth and strict quality control measures
- Comprehensive Variant Detection: SNPs, Indels, CNVs, and splicing variants
- Robust Data Analysis and Reporting: Following ACMG guidelines and incorporating evidence from literature and databases
- Validation and Reliability: Internal replication, use of reference samples, and reproducibility testing
Through this support, hospitals and medical foundations can establish NGS panels that are clinically meaningful, cost-efficient, and adaptable to their unique needs.
Rare disease diagnosis is one of the most pressing challenges in modern medicine, directly impacting patient care and quality of life. NGS panels offer a practical and powerful solution, combining speed, accuracy, and cost efficiency.
Celemics is ready to collaborate with hospitals, medical foundations, and research institutions by providing tailored NGS panel solutions—helping advance both patient diagnostics and rare disease research.
Explore Custom NGS Panels for Rare Disease Diagnosis
#RareDiseaseDiagnostics #CustomNGSPanel #GenomicTestingSolutions #HospitalGenomics #NextGenerationSequencing